Page 54 - HIV/AIDS Guidelines

12. Writing Committee of the CASCADE Collaboration. Timing of HAART initiation and clinical outcomes in human
immunodeficiency virus type 1 seroconverters. Arch Intern Med. Sep 26 2011;171(17):1560-1569.
13. Emery S, Neuhaus JA, Phillips AN, et al. Major clinical outcomes in antiretroviral therapy (ART)-naive participants and
in those not receiving ART at baseline in the SMART study. J Infect Dis. Apr 15 2008;197(8):1133-1144.
14. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med.
Aug 11 2011;365(6):493-505.
15. Mellors JW, Rinaldo CR, Jr., Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the
quantity of virus in plasma. Science. May 24 1996;272(5265):1167-1170.
16. Vlahov D, Graham N, Hoover D, et al. Prognostic indicators for AIDS and infectious disease death in HIV-infected
injection drug users: plasma viral load and CD4+ cell count. JAMA. Jan 7 1998;279(1):35-40.
17. Anastos K, Kalish LA, Hessol N, et al. The relative value of CD4 cell count and quantitative HIV-1 RNA in predicting
survival in HIV-1-infected women: results of the women's interagency HIV study. AIDS. Sep 10 1999;13(13):1717-1726.
18. O'Brien TR, Blattner WA, Waters D, et al. Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter
Hemophilia Cohort Study. JAMA. Jul 10 1996;276(2):105-110.
19. Egger M, May M, Chene G, et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a
collaborative analysis of prospective studies. Lancet. Jul 13 2002;360(9327):119-129.
20. Anastos K, Barron Y, Cohen MH, et al. The prognostic importance of changes in CD4+ cell count and HIV-1 RNA level
in women after initiating highly active antiretroviral therapy. Ann Intern Med. Feb 17 2004;140(4):256-264.
21. O'Brien WA, Hartigan PM, Martin D, et al. Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of
progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS. N Engl J Med. Feb 15 1996;334(7):426-431.
22. Hughes MD, Johnson VA, Hirsch MS, et al. Monitoring plasma HIV-1 RNA levels in addition to CD4+ lymphocyte
count improves assessment of antiretroviral therapeutic response. ACTG 241 Protocol Virology Substudy Team. Ann
Intern Med. Jun 15 1997;126(12):929-938.
23. Chene G, Sterne JA, May M, et al. Prognostic importance of initial response in HIV-1 infected patients starting potent
antiretroviral therapy: analysis of prospective studies. Lancet. Aug 30 2003;362(9385):679-686.
24. Deeks SG, Gange SJ, Kitahata MM, et al. Trends in multidrug treatment failure and subsequent mortality among
antiretroviral therapy-experienced patients with HIV infection in North America. Clin Infect Dis. Nov 15
2009;49(10):1582-1590.
25. Mugavero MJ, Napravnik S, Cole SR, et al. Viremia copy-years predicts mortality among treatment-naive HIV-infected
patients initiating antiretroviral therapy. Clin Infect Dis. Nov 2011;53(9):927-935.
26. Reekie J, Gatell JM, Yust I, et al. Fatal and nonfatal AIDS and non-AIDS events in HIV-1-positive individuals with high
CD4 cell counts according to viral load strata. AIDS. Nov 28 2011;25(18):2259-2268.
27. Szczech LA, Gupta SK, Habash R, et al. The clinical epidemiology and course of the spectrum of renal diseases
associated with HIV infection. Kidney Int. Sep 2004;66(3):1145-1152.
28. Marras D, Bruggeman LA, Gao F, et al. Replication and compartmentalization of HIV-1 in kidney epithelium of patients
with HIV-associated nephropathy. Nat Med. May 2002;8(5):522-526.
29. Estrella M, Fine DM, Gallant JE, et al. HIV type 1 RNA level as a clinical indicator of renal pathology in HIV-infected
patients. Clin Infect Dis. Aug 1 2006;43(3):377-380.
30. Atta MG, Gallant JE, Rahman MH, et al. Antiretroviral therapy in the treatment of HIV-associated nephropathy. Nephrol
Dial Transplant. Oct 2006;21(10):2809-2813.
31. Schwartz EJ, Szczech LA, Ross MJ, Klotman ME, Winston JA, Klotman PE. Highly active antiretroviral therapy and the
epidemic of HIV+ end-stage renal disease. J Am Soc Nephrol. Aug 2005;16(8):2412-2420.
32. Kalayjian RC, Franceschini N, Gupta SK, et al. Suppression of HIV-1 replication by antiretroviral therapy improves
renal function in persons with low CD4 cell counts and chronic kidney disease. AIDS. Feb 19 2008;22(4):481-487.
Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents E-13

Downloaded from http://aidsinfo.nih.gov/guidelines on 12/8/2012 EST.